Geode Capital Management, LLC Poseida Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,617,137 shares of PSTX stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,617,137

Previous 1,622,575 0.34%

Holding current value

$4.46 Million

Previous $4.74 Million 2.36%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.7 - $4.04 $14,682 - $21,969	-5,438 Reduced 0.34%	1,617,137 $4.63 Million
Q2 2024 Aug 09, 2024	BUY	$2.0 - $3.46 $118,430 - $204,883	59,215 Added 3.79%	1,622,575 $4.74 Million
Q1 2024 May 13, 2024	BUY	$2.76 - $4.13 $111,241 - $166,459	40,305 Added 2.65%	1,563,360 $4.99 Million
Q4 2023 Feb 13, 2024	BUY	$1.83 - $3.51 $191,670 - $367,630	104,738 Added 7.38%	1,523,055 $5.12 Million
Q3 2023 Nov 13, 2023	BUY	$1.62 - $2.79 $313,875 - $540,562	193,750 Added 15.82%	1,418,317 $3.38 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.4 $1.19 Million - $2.44 Million	718,477 Added 141.97%	1,224,567 $2.16 Million
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $45,023 - $127,615	14,618 Added 2.97%	506,090 $1.56 Million
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $121,278 - $232,359	36,420 Added 8.0%	491,472 $2.6 Million
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $467,947 - $868,495	192,571 Added 73.37%	455,052 $1.61 Million
Q2 2022 Aug 12, 2022	SELL	$1.87 - $5.0 $449,830 - $1.2 Million	-240,551 Reduced 47.82%	262,481 $677,000
Q1 2022 May 13, 2022	BUY	$3.22 - $7.04 $40,034 - $87,528	12,433 Added 2.53%	503,032 $2.25 Million
Q4 2021 Feb 11, 2022	BUY	$6.23 - $7.6 $709,285 - $865,260	113,850 Added 30.22%	490,599 $3.34 Million
Q3 2021 Nov 12, 2021	BUY	$7.09 - $10.71 $1,453 - $2,195	205 Added 0.05%	376,749 $2.75 Million
Q2 2021 Aug 13, 2021	SELL	$7.96 - $10.07 $208,942 - $264,327	-26,249 Reduced 6.52%	376,544 $3.77 Million
Q1 2021 May 12, 2021	BUY	$8.51 - $11.91 $1.62 Million - $2.26 Million	189,886 Added 89.19%	402,793 $3.85 Million
Q4 2020 Feb 12, 2021	BUY	$8.29 - $11.7 $199,515 - $281,583	24,067 Added 12.74%	212,907 $2.34 Million
Q3 2020 Nov 13, 2020	BUY	$8.09 - $16.25 $1.53 Million - $3.07 Million	188,840 New	188,840 $1.68 Million

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $237M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Poseida Therapeutics, Inc. Transaction History